Cargando…

Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial

RATIONALE: One hallmark of addiction is an altered neuronal reward processing. In healthy individuals (HC), reduced activity in fronto-striatal regions including the insula has been observed when a reward anticipation task was performed repeatedly. This effect could indicate a desensitization of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelz, Patricia, Genauck, Alexander, Lorenz, Robert C., Wüstenberg, Torsten, Wackerhagen, Carolin, Charlet, Katrin, Gleich, Tobias, Geisel, Olga, Heinz, Andreas, Müller, Christian A., Beck, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816215/
https://www.ncbi.nlm.nih.gov/pubmed/36538099
http://dx.doi.org/10.1007/s00213-022-06291-6
_version_ 1784864482819833856
author Pelz, Patricia
Genauck, Alexander
Lorenz, Robert C.
Wüstenberg, Torsten
Wackerhagen, Carolin
Charlet, Katrin
Gleich, Tobias
Geisel, Olga
Heinz, Andreas
Müller, Christian A.
Beck, Anne
author_facet Pelz, Patricia
Genauck, Alexander
Lorenz, Robert C.
Wüstenberg, Torsten
Wackerhagen, Carolin
Charlet, Katrin
Gleich, Tobias
Geisel, Olga
Heinz, Andreas
Müller, Christian A.
Beck, Anne
author_sort Pelz, Patricia
collection PubMed
description RATIONALE: One hallmark of addiction is an altered neuronal reward processing. In healthy individuals (HC), reduced activity in fronto-striatal regions including the insula has been observed when a reward anticipation task was performed repeatedly. This effect could indicate a desensitization of the neural reward system due to repetition. Here, we investigated this hypothesis in a cohort of patients with alcohol use disorder (AUD), who have been treated with baclofen or a placebo. The efficacy of baclofen in AUD patients has been shown to have positive clinical effects, possibly via indirectly affecting structures within the neuronal reward system. OBJECTIVES: Twenty-eight recently detoxified patients (13 receiving baclofen (BAC), 15 receiving placebo (PLA)) were investigated within a longitudinal, double-blind, and randomized pharmaco-fMRI design with an individually adjusted daily dosage of 30–270 mg. METHODS: Brain responses were captured by functional magnetic resonance imaging (fMRI) during reward anticipation while participating in a slot machine paradigm before (t1) and after 2 weeks of individual high-dose medication (t2). RESULTS: Abstinence rates were significantly higher in the BAC compared to the PLA group during the 12-week high-dose medication phase. At t1, all patients showed significant bilateral striatal activation. At t2, the BAC group showed a significant decrease in insular activation compared to the PLA group. CONCLUSIONS: By affecting insular information processing, baclofen might enable a more flexible neuronal adaptation during recurrent reward anticipation, which could resemble a desensitization as previously observed in HC. This result strengthens the modulation of the reward system as a potential mechanism of action of baclofen. TRIAL REGISTRATION: Identifier of the main trial (the BACLAD study) at clinical.gov: NCT0126665. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00213-022-06291-6.
format Online
Article
Text
id pubmed-9816215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98162152023-01-07 Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial Pelz, Patricia Genauck, Alexander Lorenz, Robert C. Wüstenberg, Torsten Wackerhagen, Carolin Charlet, Katrin Gleich, Tobias Geisel, Olga Heinz, Andreas Müller, Christian A. Beck, Anne Psychopharmacology (Berl) Original Investigation RATIONALE: One hallmark of addiction is an altered neuronal reward processing. In healthy individuals (HC), reduced activity in fronto-striatal regions including the insula has been observed when a reward anticipation task was performed repeatedly. This effect could indicate a desensitization of the neural reward system due to repetition. Here, we investigated this hypothesis in a cohort of patients with alcohol use disorder (AUD), who have been treated with baclofen or a placebo. The efficacy of baclofen in AUD patients has been shown to have positive clinical effects, possibly via indirectly affecting structures within the neuronal reward system. OBJECTIVES: Twenty-eight recently detoxified patients (13 receiving baclofen (BAC), 15 receiving placebo (PLA)) were investigated within a longitudinal, double-blind, and randomized pharmaco-fMRI design with an individually adjusted daily dosage of 30–270 mg. METHODS: Brain responses were captured by functional magnetic resonance imaging (fMRI) during reward anticipation while participating in a slot machine paradigm before (t1) and after 2 weeks of individual high-dose medication (t2). RESULTS: Abstinence rates were significantly higher in the BAC compared to the PLA group during the 12-week high-dose medication phase. At t1, all patients showed significant bilateral striatal activation. At t2, the BAC group showed a significant decrease in insular activation compared to the PLA group. CONCLUSIONS: By affecting insular information processing, baclofen might enable a more flexible neuronal adaptation during recurrent reward anticipation, which could resemble a desensitization as previously observed in HC. This result strengthens the modulation of the reward system as a potential mechanism of action of baclofen. TRIAL REGISTRATION: Identifier of the main trial (the BACLAD study) at clinical.gov: NCT0126665. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00213-022-06291-6. Springer Berlin Heidelberg 2022-12-20 2023 /pmc/articles/PMC9816215/ /pubmed/36538099 http://dx.doi.org/10.1007/s00213-022-06291-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Investigation
Pelz, Patricia
Genauck, Alexander
Lorenz, Robert C.
Wüstenberg, Torsten
Wackerhagen, Carolin
Charlet, Katrin
Gleich, Tobias
Geisel, Olga
Heinz, Andreas
Müller, Christian A.
Beck, Anne
Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
title Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
title_full Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
title_fullStr Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
title_full_unstemmed Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
title_short Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
title_sort effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fmri pilot trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816215/
https://www.ncbi.nlm.nih.gov/pubmed/36538099
http://dx.doi.org/10.1007/s00213-022-06291-6
work_keys_str_mv AT pelzpatricia effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT genauckalexander effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT lorenzrobertc effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT wustenbergtorsten effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT wackerhagencarolin effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT charletkatrin effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT gleichtobias effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT geiselolga effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT heinzandreas effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT mullerchristiana effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial
AT beckanne effectsofbaclofenoninsulargainanticipationinalcoholdependentpatientsarandomizedplacebocontrolledpharmacofmripilottrial